Search

… Job Title Research Technician I am a research technician in the Chiosis lab at Memorial Sloan Kettering Cancer Center. I am currently assisting post-doctoral scientists in investigating drugs targeting the epichaperome for the treatment of cancer and neurodegeneration. In these projects, I perform numerous

The Nursing Research Fellowship is designed to increase a nurses’ understanding and skill to conduct a small research project.

… Returning in 2025, the Nursing Research Fellowship is designed to increase capacity and infrastructure for building a research culture that fosters a spirit of inquiry for developing new knowledge and innovation in staff nurses. The Fellowship follows a practicum model as an approach to learning the

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.

… Thursday, January 9, 2025 Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century have received that approval based on their ability to target genetic changes driving tumor growth. Medical oncologists use information about the genetic

… Job Title Research Fellow Email [email protected] Office Phone 646-888-3222

Researchers from Memorial Sloan Kettering Cancer Center recently discovered that the most frequently used cancer cell lines in ovarian cancer research are not suitable models of ovarian cancer.

… Friday, July 12, 2013 Researchers from Memorial Sloan Kettering Cancer Center recently discovered that the most frequently used cancer cell lines in ovarian cancer research are not suitable models of ovarian cancer. Their findings are the result of a detailed review of genomic data that recently became

… Job Title Manager, Drug Development, MSK Therapeutics Bridge Labs Nora Kostow is Manager, Drug Development in the MSK Therapeutics Bridge Labs (TxBL) program, in the Office of Entrepreneurship & Commercialization, where she does early-stage drug discovery research. She joined MSK in September 2025. Nora

The MSK team’s goal was to get at the underlying defects in cells that these mutations cause.

… Monday, July 1, 2019 Summary MSK researchers have made new discoveries about how changes in a family of cancer-causing genes can lead to epigenetic changes. A family of genes called IDH are associated with cancer. These genes make enzymes called isocitrate dehydrogenases. The enzymes help break down

Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.

… Dr. Sawyers is an HHMI Investigator searching for molecularly targeted approaches to treat cancer. He has identified cell signaling components critical to the growth of cancer cells in chronic myeloid leukemia, prostate and other cancers, resulting in the development of multiple FDA-approved inhibitors

… Job Title Administrative Assistant Email [email protected] Office Phone 212-639-7090

… In this online support group, MSK Kids caregivers can connect with and gain support from other caregivers. It offers the space to share common feelings, learn coping strategies, and talk about the experiences of caregiving for a child receiving treatment at MSK Discussions are led by MSK Kids social